By coating tiny gel beads with lung-derived stem cells and then allowing them to self-assemble into the shapes of the air sacs found in human lungs, researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have succeeded in creating three-dimensional lung “organoids.” The laboratory-grown lung-like tissue can be used to study diseases including idiopathic pulmonary fibrosis, which has traditionally been difficult to study using conventional methods.
“While we haven’t built a fully functional lung, we’ve been able to take lung cells and place them in the correct geometrical spacing and pattern to mimic a human lung,” said Dr. Brigitte Gomperts, an associate professor of pediatric hematology/oncology and the study’s lead author.
Idiopathic pulmonary fibrosis is a chronic lung disease characterized by scarring of the lungs. The scarring makes the lungs thick and stiff, which over time results in progressively worsening shortness of breath and lack of oxygen to the brain and vital organs. After diagnosis, most people with the disease live about three to five years. Though researchers do not know what causes idiopathic pulmonary fibrosis in all cases, for a small percentage of people it runs in their families. Additionally, cigarette smoking and exposure to certain types of dust can increase the risk of developing the disease.
To study the effect of genetic mutations or drugs on lung cells, researchers have previously relied on two-dimensional cultures of the cells. But when they take cells from people with idiopathic pulmonary fibrosis and grow them on these flat cultures, the cells appear healthy. “Scientists have really not been able to model lung scarring in a dish,” said Gomperts, who is a member of the UCLA Broad Stem Cell Research Center. The inability to model idiopathic pulmonary fibrosis in the laboratory makes it difficult to study the biology of the disease and design possible treatments.
Gomperts and her colleagues started with stem cells created using cells from adult lungs. They used those cells to coat sticky hydrogel beads, and then they partitioned these beads into small wells, each only 7 millimeters across. Inside each well, the lung cells grew around the beads, which linked them and formed an evenly distributed three-dimensional pattern. To show that these tiny organoids mimicked the structure of actual lungs, the researchers compared the lab-grown tissues with real sections of human lung.
“The technique is very simple,” said Dan Wilkinson, a graduate student in the department of materials science and engineering and the paper’s first author. “We can make thousands of reproducible pieces of tissue that resemble lung and contain patient-specific cells.”
Moreover, when Wilkinson and Gomperts added certain molecular factors to the 3-D cultures, the lungs developed scars similar to those seen in the lungs of people who have idiopathic pulmonary fibrosis, something that could not be accomplished using two-dimensional cultures of these cells.
Using the new lung organoids, researchers will be able to study the biological underpinnings of lung diseases including idiopathic pulmonary fibrosis, and also test possible treatments for the diseases. To study an individual’s disease, or what drugs might work best in their case, clinicians could collect cells from the person, turn them into stem cells, coax those stem cells to differentiate into lung cells, then use those cells in 3-D cultures. Because it’s so easy to create many tiny organoids at once, researchers could screen the effect of many drugs. “This is the basis for precision medicine and personalized treatments,” Gomperts said.
The Latest on: Precision medicine
via Google News
The Latest on: Precision medicine
- Precision Medicine Software Market Rising Trends, Demands and Production Growth 2019 to 2026on November 19, 2019 at 11:57 pm
The precision medicine software market is segmented on the basis of delivery mode, end user, application, and region. Based on delivery mode, the precision medicine software market is classified into ...
- Patients Need More Education Regarding the Purpose of Precision Medicine Trialson November 19, 2019 at 11:51 am
Precision medicine may offer new hope to children with high-risk cancer, but only if families and healthcare professionals are fully educated on the benefits and limitations of precision medicine ...
- Mount Sinai Builds Supercomputer for Precision Medicine, Genomicson November 19, 2019 at 8:35 am
November 19, 2019 - Mount Sinai Health System has received a $2 million grant from the US Department of Health and Human Services to develop a precision medicine and genomics supercomputer. The second ...
- IT will be key to precision medicine’s success in 2020on November 18, 2019 at 8:49 pm
As a result, stakeholders ranging from clinicians to regulatory agencies, to professional associations, to payers have begun championing the value that precision medicine delivers in terms of better ...
- Genetic Variant Could Boost Precision Medicine for Alzheimer’son November 18, 2019 at 6:59 am
Their findings could hold important implications for precision medicine treatments of the condition. Some individuals who carry mutations in genes known to cause early onset Alzheimer’s don’t show ...
- Sidra to host symposium on Paediatric Precision Medicineon November 17, 2019 at 4:00 pm
Sidra Medicine’s upcoming CUDOS Congress 2019 based on the ‘Current Understanding on Diabetes, Obesity and Related Syndromes’ will host a symposium on Paediatric Precision Medicine. The CUDOS Congress ...
- Novel Model To Advance Cancer Precision Medicineon November 15, 2019 at 5:48 am
Combined Essentiality Scoring (CES) is the new computation model developed by researchers from the Faculty of Medicine and the Institute for Molecular Medicine (FIMM) at the University of Helsinki.
- 2020 Vision: Predictions of What May Shape Precision Medicineon November 15, 2019 at 5:27 am
As 2020 approaches, it is fair to say that significant—and perhaps surprising—advances will be made in the precision medicine and omics arenas, as there were in 2019. While we don’t know for sure what ...
- SEngine Precision Medicine Names Surgical Oncologist and Cancer Care Advocate Dr. Astrid Margossian as Chief Medical Officeron November 14, 2019 at 4:30 pm
SEATTLE, Washington, Nov. 14, 2019 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, an oncology pioneer accelerating cancer drug discovery through its proprietary diagnostic platform known as The PARIS ...
via Bing News